You can take a list of consumer stocks that can be the “next Procter & Gamble” in many different ways. Certain small- and mid-cap stocks… Read More »The Next Procter & Gamble? 3 Consumer Stocks That Investors Shouldn’t Ignore
Don’t fall into the trap of thinking you can’t beat the market. It’s total nonsense—and that goes double if you look outside stocks, to other… Read More »Yes, You CAN Beat The Market. These 7%+ Dividends Do It All The Time
As 2023 passed with no recession materializing, many investors breathed a sigh of relief, which naively may not seem supportive of targeting high-yield dividend stocks… Read More »Cash In On Growth: 3 High-Yield Dividend Stocks To Supercharge Your Income
While it’s always nice to have passive income no matter the frequency, there’s just something satisfying about monthly dividend stocks. In large part, we’ve become… Read More »7 Must-Have Monthly Dividend Stocks For Uninterrupted Income
One mistake investors make when buying dividend stocks is chasing yield. Stocks with the highest yield could be a sign a company is struggling, which… Read More »7 Tremendous Dividend Stocks With Double-Digit 5-Year Growth Rates
Remember a decade or so back, when we heard over and over again that the coming decades would be all about China? If you ignored… Read More »16 “All-American” Dividends Yielding Up To 18%
Energy midstream companies organized as master limited partnerships (MLPs) offer significant tax advantages to investors. However, there are a few “gotchas” with MLP investing, so… Read More »Get The Tax Advantages Of MLP Investing Without The K-1 Hassles
Technical analysis may still be a controversial idea to some of the old guard but it’s the only methodology I’m aware of that will give… Read More »Green Flags: 7 Stocks Flashing Buy Signals To Watch Now
Interestingly, there are no Big Pharma companies listed in the “Magnificent Seven.” Consequently, perfectly good companies like Pfizer (NYSE:PFE) are being overlooked, but that’s not… Read More »Pfizer’s 2024 Comeback: A Dividend Gem In The Pharma Market
Magnificent Seven? Tired. Dividend Six? Wired. Plain vanilla investors fawn over chipmakers and AI stocks. They hope they can buy them high, and sell them… Read More »Magnificent 7 Move Over: “Dividend 6” Yields Up To 8.3%